


VCIRC.ORG is a non-profit organization that is building a teaching laboratory devoted to the study of molecular cardiovascular medicine in Roanoke, Virginia. VCIRC.ORG exists to develop our cardiovascular biotechnology leaders of tomorrow. We are also working to study and improve the prevention and treatment of diseases related to inflammation and hypoxia such as heart attack and stroke. Please click on FUNDRAISING to learn more about dietary supplementation with EPA. |
BACKGROUND
VCIRC.ORG was conceived in 2006 and incorporated in the Commonwealth of Virginia on August 8, 2007. IRS tax-exempt status under section 501(c)(3) was granted August 20, 2009, retroactive to date of incorporation. VCIRC.ORG is located in Roanoke, adjacent to the Carilion Clinic, and sits across a park from the new Virginia Tech Carilion Medical School. VCIRC.ORG is in a position today help build the future prosperity of Roanoke and will contribute to the development of our community by enabling understanding of the mechanisms of cardiovascular diseases and providing an environment within which new clinical scientists can be trained in the art and science of molecular cardiovascular medicine. |
OUR RESEARCH

Unanswered Questions
VCIRC.ORG exists to address as yet unanswered questions regarding the effects of a lack of oxygen, known as hypoxia, on inflammation in blood vessels.

Working for Better Results
We need to learn about gene expression in blood vessels during medical therapy for human cardiovascular diseases, through a program of basic scientific research and education.